Breaking News

Breaking News
1st Patient Apparent Success Story
2nd Patient Apparent Success Story
3rd Patient Apparent Success Story
4th Patient Apparent Success Story
News Release Subscription

Required *

Field not valid (required or bad value)
Field not valid (required or bad value)
Field not valid (required or bad value)
 
Cannabis Science CFO Speaks at a Conference

Cannabis Science CFO Speaks at a Conference Sponsored By the Mexican Congress, A Political Debate on the Regulation of the Cannabis Plant in Mexico

April 20, 2009

SAN FRANCISCO--(BUSINESS WIRE)--Cannabis Science Inc. (OTCBB: GFON.OB): Mr. Richard Cowan, Chief Financial Officer, reported to the Board following his successful presentation to the Legislative Prospects and Public Policy on Cannabis Conference sponsored by the Mexican Congreso de la Unión last week. Mr. Cowan’s panel’s presentation brought the conference to a close on April 15, 2009, the day before U.S. President Barack Obama's meeting with Mexican President Felipe Calderon in preparation for the 2009 Summit of the Americas. The three-day conference, held in the magnificent Mexican Congressional Building in Mexico City from April 13 to 15, covered a broad range of cannabis issues, including medical and industrial use.

Cowan stated, “There is a global demand for pharmaceutical cannabis products being developed by CSI as a result of new scientific discoveries. We strongly believe that these new discoveries will help the Obama Administration move forward with the Federal approval of Medical Cannabis to treat a wide variety of diseases, including cancer, bird flu, and neuromuscular disorders, as well as chronic pain and autoimmune disorders.”

Please visit Mr. Cowan’s website www.MarijuanaNews.com for a complete report on the conference.

About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

About The Cannabis Science 420 Commemorative Certificate Program
April 20th is a special holiday when cannabis patients and advocates around the world celebrate the benefits of this unique medicinal herb. To commemorate this special holiday we have now officially launched our Cannabis Science Inc., 420 Commemorative Certificate Program. Please visit www.cannabisscience.com for more information.

You should not place undue reliance on forward-looking statements in this press release. This press release contains forward-looking statements that involve risks and uncertainties. Words such as “will,” “anticipates,” “believes,” “plans,” “goal,” “expects,” “future,” “intends” and similar expressions are used to identify these forward-looking statements. Actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including the risks we face as described in this press release.

Cannabis Science Inc.
Steven W. Kubby
President & CEO
888-889-0888
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
www.cannabisscience.com

 

Cannabis Science Contact Info  |  Telephone: 1 888.889.0888  |  Fax: 1 866.943.5085   |  Email: info@cannabisscience.com